EDINBURG, Va., March 01, 2017 -- Shenandoah Telecommunications Company (“Shentel”) (NASDAQ:SHEN) today announced that Earle MacKenzie, Chief Operating Officer, will present at the Raymond James 38th Annual Institutional Investors Conference on Wednesday, March 8, 2017 at 11:00 a.m. Eastern Time. The conference will be held at the JW Marriott Grande Lakes in Orlando, Florida. Mr. MacKenzie will be available for one-on-one meetings on Tuesday, March 7 and through the morning on Wednesday, March 8.
About Shenandoah Telecommunications
Shenandoah Telecommunications Company (Shentel) provides a broad range of diversified communications services through its high speed, state-of-the-art network to customers in the Mid-Atlantic United States. The Company’s services include: wireless voice and data; cable video, internet and voice; fiber network and services; and local and long distance telephone. Shentel is the exclusive personal communications service (“PCS”) Affiliate of Sprint in portions of Pennsylvania, Maryland, Virginia and West Virginia. For more information, please visit www.shentel.com.
CONTACTS: Shenandoah Telecommunications, Inc. Adele Skolits CFO and VP of Finance 540-984-5161 [email protected] Or John Nesbett/Jennifer Belodeau Institutional Marketing Services (IMS) 203-972-9200 [email protected]


L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 



